The U.S. Food and Drug Administration has cleared the first set of mobile medical apps that allow diabetics to automatically and securely share data from a continuous glucose monitor (CGM) with caregivers in real-time via an Apple mobile device.

According to the FDA, the Dexcom Share system manufactured by San Diego-based Dexcom, Inc., is the first of its kind to offer a legally marketed solution for real-time remote monitoring of a patient’s CGM data. CGMs are worn externally and are devices that include a small, wire-like sensor inserted just under the skin that provides a steady stream of information about glucose levels.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access